Search

Agnieszka Boesen

Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1050
Issued Applications
614
Pending Applications
117
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6119151 [patent_doc_number] => 20110076672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Phage-Mediated Bioluminescent Detection of Yersinia Pestis' [patent_app_type] => utility [patent_app_number] => 12/992488 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12261 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076672.pdf [firstpage_image] =>[orig_patent_app_number] => 12992488 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/992488
Phage-mediated bioluminescent detection of Yersinia pestis May 12, 2009 Issued
Array ( [id] => 8158514 [patent_doc_number] => 20120100180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'METHODS FOR PROLIFERATION OF ANTIGEN-SPECIFIC T CELLS' [patent_app_type] => utility [patent_app_number] => 13/254039 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5193 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100180.pdf [firstpage_image] =>[orig_patent_app_number] => 13254039 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/254039
Methods for proliferation of antigen-specific T cells Apr 29, 2009 Issued
Array ( [id] => 5392554 [patent_doc_number] => 20090209867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'METHOD FOR RAPID SCREENING OF MAD COW DISEASE AND OTHER TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES' [patent_app_type] => utility [patent_app_number] => 12/429330 [patent_app_country] => US [patent_app_date] => 2009-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2532 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209867.pdf [firstpage_image] =>[orig_patent_app_number] => 12429330 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/429330
METHOD FOR RAPID SCREENING OF MAD COW DISEASE AND OTHER TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES Apr 23, 2009 Abandoned
Array ( [id] => 9239387 [patent_doc_number] => 08604179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Nucleic acid comprising chimeric gene derived from hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 12/989592 [patent_app_country] => US [patent_app_date] => 2009-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13462 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989592 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989592
Nucleic acid comprising chimeric gene derived from hepatitis C virus Apr 23, 2009 Issued
Array ( [id] => 5391210 [patent_doc_number] => 20090208523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Adjuvant for vaccines' [patent_app_type] => utility [patent_app_number] => 12/386753 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2855 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208523.pdf [firstpage_image] =>[orig_patent_app_number] => 12386753 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386753
Adjuvant for vaccines Apr 21, 2009 Abandoned
Array ( [id] => 5551869 [patent_doc_number] => 20090285855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS (JEV) INFECTION AND A METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/426306 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14233 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285855.pdf [firstpage_image] =>[orig_patent_app_number] => 12426306 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/426306
RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS (JEV) INFECTION AND A METHOD THEREOF Apr 19, 2009 Abandoned
Array ( [id] => 6054619 [patent_doc_number] => 20110110979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/988455 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12878 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110979.pdf [firstpage_image] =>[orig_patent_app_number] => 12988455 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/988455
METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES Mar 31, 2009 Abandoned
Array ( [id] => 5379732 [patent_doc_number] => 20090191571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Isolation and Detection of Pathogenic Prions' [patent_app_type] => utility [patent_app_number] => 12/411337 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 31643 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191571.pdf [firstpage_image] =>[orig_patent_app_number] => 12411337 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/411337
Isolation and Detection of Pathogenic Prions Mar 24, 2009 Abandoned
Array ( [id] => 4628910 [patent_doc_number] => 08007792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 12/408080 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 32 [patent_no_of_words] => 18773 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007792.pdf [firstpage_image] =>[orig_patent_app_number] => 12408080 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/408080
Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions Mar 19, 2009 Issued
Array ( [id] => 6202308 [patent_doc_number] => 20110065094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'METHOD AND KIT FOR DETECTION/IDENTIFICATION OF VIRUS-INFECTED CELL' [patent_app_type] => utility [patent_app_number] => 12/933736 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9567 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065094.pdf [firstpage_image] =>[orig_patent_app_number] => 12933736 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/933736
METHOD AND KIT FOR DETECTION/IDENTIFICATION OF VIRUS-INFECTED CELL Mar 16, 2009 Abandoned
Array ( [id] => 5969110 [patent_doc_number] => 20110150912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Avian influenza virus live attenuated vaccine and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/381550 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25602 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150912.pdf [firstpage_image] =>[orig_patent_app_number] => 12381550 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/381550
Avian influenza virus live attenuated vaccine and uses thereof Mar 12, 2009 Issued
Array ( [id] => 5929380 [patent_doc_number] => 20110039339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Process, Vectors and Engineered Cell Lines for Enhanced Large-Scale Transfection' [patent_app_type] => utility [patent_app_number] => 12/989898 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6370 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039339.pdf [firstpage_image] =>[orig_patent_app_number] => 12989898 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989898
Process, vectors and engineered cell lines for enhanced large-scale transfection Mar 8, 2009 Issued
Array ( [id] => 5534204 [patent_doc_number] => 20090233992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'HEPATITIS C VIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 12/396747 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 22345 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12396747 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/396747
Hepatitis C virus vaccine Mar 2, 2009 Issued
Array ( [id] => 5514287 [patent_doc_number] => 20090214593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'IMMUNOGEN PLATFORM' [patent_app_type] => utility [patent_app_number] => 12/371898 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 73746 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214593.pdf [firstpage_image] =>[orig_patent_app_number] => 12371898 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/371898
IMMUNOGEN PLATFORM Feb 15, 2009 Abandoned
Array ( [id] => 5403951 [patent_doc_number] => 20090239265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'VIRUS LIKE PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/367195 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9603 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239265.pdf [firstpage_image] =>[orig_patent_app_number] => 12367195 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/367195
VIRUS LIKE PARTICLES Feb 5, 2009 Abandoned
Array ( [id] => 6125466 [patent_doc_number] => 20110086048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS CO-RECEPTOR TROPISM IN AVIREMIC SUBJECTS' [patent_app_type] => utility [patent_app_number] => 12/866424 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7444 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086048.pdf [firstpage_image] =>[orig_patent_app_number] => 12866424 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/866424
DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS CO-RECEPTOR TROPISM IN AVIREMIC SUBJECTS Feb 5, 2009 Abandoned
Array ( [id] => 5533054 [patent_doc_number] => 20090232842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'HPV Vaccine Comprising Peptides From Host Cell Proteins' [patent_app_type] => utility [patent_app_number] => 12/364849 [patent_app_country] => US [patent_app_date] => 2009-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10454 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232842.pdf [firstpage_image] =>[orig_patent_app_number] => 12364849 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/364849
HPV Vaccine Comprising Peptides From Host Cell Proteins Feb 2, 2009 Abandoned
Array ( [id] => 5403527 [patent_doc_number] => 20090238841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'HIV VACCINE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/364294 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22672 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238841.pdf [firstpage_image] =>[orig_patent_app_number] => 12364294 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/364294
HIV VACCINE FORMULATIONS Feb 1, 2009 Abandoned
Array ( [id] => 6195429 [patent_doc_number] => 20110027183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver' [patent_app_type] => utility [patent_app_number] => 12/864197 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14499 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027183.pdf [firstpage_image] =>[orig_patent_app_number] => 12864197 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/864197
Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver Jan 25, 2009 Issued
Array ( [id] => 6148802 [patent_doc_number] => 20110020397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'HYDROPHOBIC MODIFIED PRES-DERIVED PEPTIDES OF HEPATITIS B VIRUS (HBV) AND THEIR USE AS HBV AND HDV ENTRY INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/863663 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13622 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020397.pdf [firstpage_image] =>[orig_patent_app_number] => 12863663 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/863663
Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors Jan 25, 2009 Issued
Menu